艾伦德罗纳特可以提高骨质疏松症患者的存活率吗? 随机对照试验的元分析
Rui Sun1, Zhibin Lan1, Gang Wu1
1The Third Ward of Orthopaedic Department, General Hospital of Ningxia Medical University, Yinchuan, PR China.
Science progress
|September 3, 2025
概括
根据这一分析,阿伦德罗纳特治疗不会改善骨质疏松症患者的生存率. 骨质疏松症治疗的重点应该是预防骨折.
科学领域:
- 骨代谢和内分泌学
- 老年医学
- 药理学
背景情况:
- 骨质疏松症是严重的公共卫生问题,主要通过像阿伦德罗纳特这样的双酸盐治疗.
- 在骨质疏松症患者的骨折风险降低方面已有很好的证据.
- 艾伦德罗纳特对整体存活时间的影响尚不清楚.
研究的目的:
- 对阿伦德罗纳酸对骨质疏松症生存的影响进行系统审查和元分析.
- 为了确定阿伦德罗纳特是否比其抗骨折功效更有生存益处.
主要方法:
- 在主要数据库 (Embase, Web of Science, Medline, Cochrane, ClinicalTrials.gov) 中进行全面的文献搜索.
- 包括针对阿伦德罗纳酸和骨质疏松症的随机控制试验 (RCT).
- 主要结果:整体存活率;使用固定或随机效应模型进行分析;GRADE和漏斗图用于质量和偏差评估.
主要成果:
- 其中包括了13项与15560名参与者的RCT.
- 阿伦德罗纳特治疗没有显著改善生存率 (RR,1. 00;95% CI,1. 00-1. 01).
- 亚组分析 (绝经后妇女,试验≥3年) 证实没有生存益处;观察到低异质性和没有出版偏差.
结论:
- 在骨质疏松症患者中,阿伦德罗纳特治疗没有提高整体存活率.
- 艾伦德罗纳酸的确定的好处在于减少骨折风险.
- 目前的骨质疏松症治疗应优先考虑骨折预防策略.
相关概念视频
01:29Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:21Drug Distribution: Tissue Binding
3.2K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.2K
01:20Actuarial Approach
132
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
132
01:20Study Designs in Epidemiology
410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410
01:31Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K